Personal tools

FF:10003-101A7: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
(Undo revision 1839692 by Autoedit (talk))
Line 37: Line 37:
|id=FF:10003-101A7
|id=FF:10003-101A7
|is_a=EFO:0002091;;FF:0000004;;FF:0000103;;FF:0000343
|is_a=EFO:0002091;;FF:0000004;;FF:0000103;;FF:0000343
|is_obsolete=
|name=SABiosciences XpressRef Mouse Universal Total RNA, pool1
|name=SABiosciences XpressRef Mouse Universal Total RNA, pool1
|namespace=FANTOM5
|namespace=FANTOM5
Line 70: Line 69:
|sample_ethnicity=
|sample_ethnicity=
|sample_experimental_condition=
|sample_experimental_condition=
|sample_gostat=GO:0044464;cell part;0!GO:0005622;intracellular;0!GO:0044424;intracellular part;3.05030023859617e-282!GO:0005737;cytoplasm;8.48111009365538e-189!GO:0044444;cytoplasmic part;6.96788228969975e-147!GO:0043227;membrane-bound organelle;5.48955158312082e-99!GO:0043231;intracellular membrane-bound organelle;5.48955158312082e-99!GO:0043226;organelle;2.37750604268466e-92!GO:0043229;intracellular organelle;4.14854752212074e-92!GO:0044422;organelle part;8.6322602934089e-71!GO:0044446;intracellular organelle part;1.59772886685533e-69!GO:0005515;protein binding;1.46935131740421e-68!GO:0005739;mitochondrion;6.10818656036047e-62!GO:0044237;cellular metabolic process;7.41622032822577e-59!GO:0044238;primary metabolic process;1.14817315095271e-54!GO:0031090;organelle membrane;9.61264912412914e-51!GO:0032991;macromolecular complex;3.70077153814542e-42!GO:0009058;biosynthetic process;3.91461185919483e-41!GO:0044429;mitochondrial part;1.34345399180002e-40!GO:0043233;organelle lumen;1.25129435235659e-39!GO:0031974;membrane-enclosed lumen;1.25129435235659e-39!GO:0030529;ribonucleoprotein complex;7.36382710369961e-39!GO:0019538;protein metabolic process;1.48211858943318e-37!GO:0005783;endoplasmic reticulum;9.44196045440293e-37!GO:0044249;cellular biosynthetic process;3.71869520119179e-35!GO:0044260;cellular macromolecule metabolic process;3.05149648782865e-33!GO:0005829;cytosol;4.43892666842633e-33!GO:0044267;cellular protein metabolic process;1.04779682892829e-31!GO:0003723;RNA binding;3.19746062207034e-31!GO:0031967;organelle envelope;5.15749582897859e-31!GO:0031975;envelope;1.01476989225712e-30!GO:0016491;oxidoreductase activity;1.35634055216374e-30!GO:0033036;macromolecule localization;2.57629688980041e-30!GO:0015031;protein transport;2.57661049788601e-29!GO:0006412;translation;8.21549248436219e-29!GO:0043170;macromolecule metabolic process;9.33836351368226e-29!GO:0045184;establishment of protein localization;1.04955390565996e-28!GO:0008104;protein localization;2.77352650995721e-28!GO:0044432;endoplasmic reticulum part;3.11021996140623e-27!GO:0009059;macromolecule biosynthetic process;9.06460098939299e-27!GO:0016043;cellular component organization and biogenesis;9.5059283262045e-27!GO:0006082;organic acid metabolic process;2.35156346355683e-26!GO:0005840;ribosome;3.28959666684209e-26!GO:0019752;carboxylic acid metabolic process;1.38916273837502e-25!GO:0005740;mitochondrial envelope;1.38916273837502e-25!GO:0031966;mitochondrial membrane;3.97103196005872e-25!GO:0019866;organelle inner membrane;2.89636241306523e-24!GO:0044428;nuclear part;3.85256619730302e-24!GO:0044248;cellular catabolic process;8.83995391944525e-24!GO:0005743;mitochondrial inner membrane;1.58476619436182e-23!GO:0012505;endomembrane system;2.29137389408133e-23!GO:0003735;structural constituent of ribosome;1.62180433816602e-22!GO:0005789;endoplasmic reticulum membrane;5.34770015990084e-22!GO:0042175;nuclear envelope-endoplasmic reticulum network;6.61440003521857e-22!GO:0046907;intracellular transport;9.07504475141402e-22!GO:0044255;cellular lipid metabolic process;9.87915571881928e-22!GO:0006950;response to stress;1.7669960858115e-21!GO:0006629;lipid metabolic process;1.96598830841777e-21!GO:0043234;protein complex;4.18098108963771e-21!GO:0031980;mitochondrial lumen;8.92413692927842e-21!GO:0005759;mitochondrial matrix;8.92413692927842e-21!GO:0006886;intracellular protein transport;1.92968891661891e-20!GO:0033279;ribosomal subunit;2.17504446963481e-20!GO:0006091;generation of precursor metabolites and energy;2.95490799110758e-19!GO:0016071;mRNA metabolic process;8.73172985064258e-19!GO:0008380;RNA splicing;2.1426804877858e-18!GO:0009056;catabolic process;6.91010103059186e-18!GO:0006119;oxidative phosphorylation;2.11436426538457e-17!GO:0065003;macromolecular complex assembly;2.12632038454684e-17!GO:0009055;electron carrier activity;5.32978506747479e-17!GO:0048770;pigment granule;5.43161503822343e-17!GO:0042470;melanosome;5.43161503822343e-17!GO:0032787;monocarboxylic acid metabolic process;9.92390942493719e-17!GO:0008134;transcription factor binding;7.45526701397208e-16!GO:0006396;RNA processing;1.70520402091139e-15!GO:0022607;cellular component assembly;1.70520402091139e-15!GO:0006397;mRNA processing;2.36456676393689e-15!GO:0031981;nuclear lumen;3.46419603465979e-15!GO:0005830;cytosolic ribosome (sensu Eukaryota);3.52871792924761e-15!GO:0051186;cofactor metabolic process;3.76565843150706e-15!GO:0016192;vesicle-mediated transport;4.25611580897456e-14!GO:0006457;protein folding;7.1930165548265e-14!GO:0051641;cellular localization;9.30530419148628e-14!GO:0051649;establishment of cellular localization;1.75071161543891e-13!GO:0044445;cytosolic part;2.28247395552078e-13!GO:0008219;cell death;2.38428635294063e-13!GO:0016265;death;2.38428635294063e-13!GO:0005681;spliceosome;3.48193410965269e-13!GO:0044265;cellular macromolecule catabolic process;4.49524984207713e-13!GO:0006915;apoptosis;7.18144710654988e-13!GO:0012501;programmed cell death;7.18144710654988e-13!GO:0044455;mitochondrial membrane part;1.3365288050155e-12!GO:0005746;mitochondrial respiratory chain;1.4538943925457e-12!GO:0048523;negative regulation of cellular process;1.94155645311926e-12!GO:0006118;electron transport;3.20208768807143e-12!GO:0002526;acute inflammatory response;3.29834316285721e-12!GO:0009611;response to wounding;4.66412784797384e-12!GO:0015935;small ribosomal subunit;5.08291744830376e-12!GO:0048519;negative regulation of biological process;5.44250101664117e-12!GO:0006732;coenzyme metabolic process;5.81651666245463e-12!GO:0016655;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;6.73878542829778e-12!GO:0005773;vacuole;7.15996464919945e-12!GO:0005794;Golgi apparatus;7.72964043827111e-12!GO:0048037;cofactor binding;9.3390804233833e-12!GO:0051603;proteolysis involved in cellular protein catabolic process;1.03920942735909e-11!GO:0016874;ligase activity;1.76335712063148e-11!GO:0019941;modification-dependent protein catabolic process;2.07543301922307e-11!GO:0043632;modification-dependent macromolecule catabolic process;2.07543301922307e-11!GO:0006511;ubiquitin-dependent protein catabolic process;2.52677420391378e-11!GO:0008202;steroid metabolic process;2.55752479417259e-11!GO:0050136;NADH dehydrogenase (quinone) activity;2.56336985617386e-11!GO:0003954;NADH dehydrogenase activity;2.56336985617386e-11!GO:0008137;NADH dehydrogenase (ubiquinone) activity;2.56336985617386e-11!GO:0044257;cellular protein catabolic process;3.05889974990194e-11!GO:0006605;protein targeting;3.2666600938249e-11!GO:0006807;nitrogen compound metabolic process;4.01671818377585e-11!GO:0005792;microsome;4.0736657327084e-11!GO:0051082;unfolded protein binding;5.88124626538061e-11!GO:0022618;protein-RNA complex assembly;5.88124626538061e-11!GO:0042598;vesicular fraction;8.18632293346818e-11!GO:0005634;nucleus;8.76945301956036e-11!GO:0022613;ribonucleoprotein complex biogenesis and assembly;1.31673711147678e-10!GO:0000323;lytic vacuole;1.33801272190988e-10!GO:0005764;lysosome;1.33801272190988e-10!GO:0009057;macromolecule catabolic process;1.77908258603262e-10!GO:0005654;nucleoplasm;2.31046861977807e-10!GO:0005793;ER-Golgi intermediate compartment;4.77153559926772e-10!GO:0002541;activation of plasma proteins during acute inflammatory response;5.39093336763951e-10!GO:0006956;complement activation;5.39093336763951e-10!GO:0003712;transcription cofactor activity;5.39093336763951e-10!GO:0000502;proteasome complex (sensu Eukaryota);6.14565293859583e-10!GO:0008610;lipid biosynthetic process;7.8681124553962e-10!GO:0006066;alcohol metabolic process;8.92572998216858e-10!GO:0043285;biopolymer catabolic process;9.44858835321309e-10!GO:0051246;regulation of protein metabolic process;9.54906407123334e-10!GO:0030964;NADH dehydrogenase complex (quinone);1.53752613940447e-09!GO:0045271;respiratory chain complex I;1.53752613940447e-09!GO:0005747;mitochondrial respiratory chain complex I;1.53752613940447e-09!GO:0016651;oxidoreductase activity, acting on NADH or NADPH;1.62624288126371e-09!GO:0006631;fatty acid metabolic process;1.8735148301838e-09!GO:0006461;protein complex assembly;2.02052052289033e-09!GO:0048193;Golgi vesicle transport;2.0702340918378e-09!GO:0042775;organelle ATP synthesis coupled electron transport;2.0702340918378e-09!GO:0042773;ATP synthesis coupled electron transport;2.0702340918378e-09!GO:0006958;complement activation, classical pathway;2.09386888661603e-09!GO:0009308;amine metabolic process;2.1371193082848e-09!GO:0015934;large ribosomal subunit;2.16377550823669e-09!GO:0006120;mitochondrial electron transport, NADH to ubiquinone;3.13718648306148e-09!GO:0005843;cytosolic small ribosomal subunit (sensu Eukaryota);3.76543631911704e-09!GO:0030163;protein catabolic process;4.40306884110747e-09!GO:0008135;translation factor activity, nucleic acid binding;4.99661128863504e-09!GO:0005768;endosome;5.00636899953281e-09!GO:0050662;coenzyme binding;5.21846482602331e-09!GO:0006520;amino acid metabolic process;6.59302775904463e-09!GO:0002455;humoral immune response mediated by circulating immunoglobulin;7.84350005370344e-09!GO:0016614;oxidoreductase activity, acting on CH-OH group of donors;1.07837903640342e-08!GO:0016125;sterol metabolic process;1.28109847010803e-08!GO:0046961;hydrogen ion transporting ATPase activity, rotational mechanism;1.35025920696064e-08!GO:0006519;amino acid and derivative metabolic process;1.50637272832847e-08!GO:0043069;negative regulation of programmed cell death;1.57278038030358e-08!GO:0044451;nucleoplasm part;1.8524451826499e-08!GO:0043066;negative regulation of apoptosis;1.96770421041622e-08!GO:0016616;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;2.85234292297349e-08!GO:0006446;regulation of translational initiation;2.85451059735841e-08!GO:0006913;nucleocytoplasmic transport;4.04407317346973e-08!GO:0016817;hydrolase activity, acting on acid anhydrides;4.44782097105348e-08!GO:0016044;membrane organization and biogenesis;4.46087570788975e-08!GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;5.10452916649362e-08!GO:0005761;mitochondrial ribosome;5.85123768584608e-08!GO:0000313;organellar ribosome;5.85123768584608e-08!GO:0042981;regulation of apoptosis;6.33002693212525e-08!GO:0016462;pyrophosphatase activity;6.33002693212525e-08!GO:0000166;nucleotide binding;6.33002693212525e-08!GO:0016627;oxidoreductase activity, acting on the CH-CH group of donors;6.35888676064194e-08!GO:0051169;nuclear transport;9.13691392234618e-08!GO:0006996;organelle organization and biogenesis;1.20584807323143e-07!GO:0008203;cholesterol metabolic process;1.24910489047153e-07!GO:0043067;regulation of programmed cell death;1.32333906472688e-07!GO:0031988;membrane-bound vesicle;1.44154561939881e-07!GO:0016564;transcription repressor activity;1.51661463470344e-07!GO:0046933;hydrogen ion transporting ATP synthase activity, rotational mechanism;1.54440020416858e-07!GO:0031982;vesicle;1.61774880438207e-07!GO:0017111;nucleoside-triphosphatase activity;1.8706647751043e-07!GO:0015986;ATP synthesis coupled proton transport;2.48776160547329e-07!GO:0015985;energy coupled proton transport, down electrochemical gradient;2.48776160547329e-07!GO:0005777;peroxisome;2.78152501906194e-07!GO:0042579;microbody;2.78152501906194e-07!GO:0006413;translational initiation;3.05850857039676e-07!GO:0008565;protein transporter activity;3.09298728937129e-07!GO:0016023;cytoplasmic membrane-bound vesicle;3.12214547662913e-07!GO:0006916;anti-apoptosis;3.40998406667452e-07!GO:0031410;cytoplasmic vesicle;3.81101111775144e-07!GO:0051187;cofactor catabolic process;4.08896339574326e-07!GO:0003743;translation initiation factor activity;4.67076231281189e-07!GO:0045333;cellular respiration;4.6915646407183e-07!GO:0005842;cytosolic large ribosomal subunit (sensu Eukaryota);4.7951358527599e-07!GO:0051789;response to protein stimulus;4.84938308779287e-07!GO:0006986;response to unfolded protein;4.84938308779287e-07!GO:0044262;cellular carbohydrate metabolic process;5.96366160855921e-07!GO:0015980;energy derivation by oxidation of organic compounds;8.5466114309472e-07!GO:0007599;hemostasis;8.934113980239e-07!GO:0009060;aerobic respiration;9.46372899607842e-07!GO:0048518;positive regulation of biological process;9.79325450086883e-07!GO:0017038;protein import;1.05216433343813e-06!GO:0030036;actin cytoskeleton organization and biogenesis;1.08941736495403e-06!GO:0006366;transcription from RNA polymerase II promoter;1.13525126449947e-06!GO:0006512;ubiquitin cycle;1.13525126449947e-06!GO:0007596;blood coagulation;1.17487608058753e-06!GO:0005635;nuclear envelope;1.40663506238237e-06!GO:0031324;negative regulation of cellular metabolic process;1.43755377117039e-06!GO:0003714;transcription corepressor activity;1.52842284650391e-06!GO:0010467;gene expression;1.59818278117124e-06!GO:0006752;group transfer coenzyme metabolic process;1.61208364376169e-06!GO:0006954;inflammatory response;1.61208364376169e-06!GO:0002253;activation of immune response;1.61208364376169e-06!GO:0019899;enzyme binding;1.62173432676378e-06!GO:0000398;nuclear mRNA splicing, via spliceosome;1.7337350397524e-06!GO:0000375;RNA splicing, via transesterification reactions;1.7337350397524e-06!GO:0000377;RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;1.7337350397524e-06!GO:0016604;nuclear body;1.77809424709295e-06!GO:0019829;cation-transporting ATPase activity;2.04419857323217e-06!GO:0006694;steroid biosynthetic process;2.28580810172533e-06!GO:0006869;lipid transport;2.36142015152839e-06!GO:0009605;response to external stimulus;2.61560219581846e-06!GO:0006099;tricarboxylic acid cycle;2.62501717888319e-06!GO:0046356;acetyl-CoA catabolic process;2.62501717888319e-06!GO:0042060;wound healing;2.95051442054892e-06!GO:0050817;coagulation;3.01854859460974e-06!GO:0042221;response to chemical stimulus;3.28460235474295e-06!GO:0007243;protein kinase cascade;3.61016010184025e-06!GO:0016607;nuclear speck;3.64934977477485e-06!GO:0030029;actin filament-based process;3.87438657012196e-06!GO:0009109;coenzyme catabolic process;4.30765711877539e-06!GO:0008361;regulation of cell size;4.30765711877539e-06!GO:0043122;regulation of I-kappaB kinase/NF-kappaB cascade;4.34761919846932e-06!GO:0008092;cytoskeletal protein binding;4.43042321440194e-06!GO:0051188;cofactor biosynthetic process;4.7867017930891e-06!GO:0016469;proton-transporting two-sector ATPase complex;4.84695969268524e-06!GO:0016049;cell growth;5.1602493499524e-06!GO:0008639;small protein conjugating enzyme activity;5.48882852791787e-06!GO:0009892;negative regulation of metabolic process;5.5757702189174e-06!GO:0042802;identical protein binding;5.62145798918389e-06!GO:0031252;leading edge;5.90749503690675e-06!GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB cascade;5.91073347713312e-06!GO:0006957;complement activation, alternative pathway;7.21703444701074e-06!GO:0006754;ATP biosynthetic process;7.36049265865031e-06!GO:0006753;nucleoside phosphate metabolic process;7.36049265865031e-06!GO:0004842;ubiquitin-protein ligase activity;7.47994478054524e-06!GO:0015078;hydrogen ion transmembrane transporter activity;7.48728127542792e-06!GO:0046034;ATP metabolic process;7.94981638058173e-06!GO:0005788;endoplasmic reticulum lumen;7.94981638058173e-06!GO:0006084;acetyl-CoA metabolic process;7.95514976544669e-06!GO:0005319;lipid transporter activity;8.78961086240266e-06!GO:0001558;regulation of cell growth;9.32105358194103e-06!GO:0006897;endocytosis;9.46377016112172e-06!GO:0010324;membrane invagination;9.46377016112172e-06!GO:0009199;ribonucleoside triphosphate metabolic process;1.0011342701866e-05!GO:0005506;iron ion binding;1.04671435593012e-05!GO:0019439;aromatic compound catabolic process;1.31649842734775e-05!GO:0009142;nucleoside triphosphate biosynthetic process;1.35747796973136e-05!GO:0009201;ribonucleoside triphosphate biosynthetic process;1.35747796973136e-05!GO:0044270;nitrogen compound catabolic process;1.40326365557265e-05!GO:0016064;immunoglobulin mediated immune response;1.46319446519148e-05!GO:0009205;purine ribonucleoside triphosphate metabolic process;1.5827785702337e-05!GO:0009144;purine nucleoside triphosphate metabolic process;1.5827785702337e-05!GO:0051170;nuclear import;1.61546394558097e-05!GO:0006888;ER to Golgi vesicle-mediated transport;1.71210869183533e-05!GO:0009063;amino acid catabolic process;1.71771955344503e-05!GO:0005770;late endosome;1.9001874625613e-05!GO:0009141;nucleoside triphosphate metabolic process;1.93828632768229e-05!GO:0046983;protein dimerization activity;1.93828632768229e-05!GO:0046483;heterocycle metabolic process;1.95256362936077e-05!GO:0019787;small conjugating protein ligase activity;1.96267609405073e-05!GO:0016879;ligase activity, forming carbon-nitrogen bonds;2.01014801549376e-05!GO:0006606;protein import into nucleus;2.11839746700773e-05!GO:0009206;purine ribonucleoside triphosphate biosynthetic process;2.13429831772496e-05!GO:0009145;purine nucleoside triphosphate biosynthetic process;2.13429831772496e-05!GO:0046930;pore complex;2.27188552375579e-05!GO:0048522;positive regulation of cellular process;2.99831852606721e-05!GO:0000267;cell fraction;3.09271877064654e-05!GO:0005730;nucleolus;3.12503020589335e-05!GO:0003713;transcription coactivator activity;3.16508544358364e-05!GO:0008286;insulin receptor signaling pathway;3.41228102869412e-05!GO:0001666;response to hypoxia;3.65597754406327e-05!GO:0019724;B cell mediated immunity;3.69238493296566e-05!GO:0016126;sterol biosynthetic process;3.83864159560778e-05!GO:0016787;hydrolase activity;3.83976917818492e-05!GO:0009259;ribonucleotide metabolic process;4.0265520623335e-05!GO:0030120;vesicle coat;4.04013605098131e-05!GO:0030662;coated vesicle membrane;4.04013605098131e-05!GO:0048475;coated membrane;4.05068625725956e-05!GO:0030117;membrane coat;4.05068625725956e-05!GO:0017076;purine nucleotide binding;4.19135043562309e-05!GO:0006163;purine nucleotide metabolic process;4.24714313472131e-05!GO:0009310;amine catabolic process;4.72695608210414e-05!GO:0006613;cotranslational protein targeting to membrane;4.91220963702744e-05!GO:0007249;I-kappaB kinase/NF-kappaB cascade;4.98927621144626e-05!GO:0001944;vasculature development;5.88356874127975e-05!GO:0009150;purine ribonucleotide metabolic process;7.09141447422419e-05!GO:0009108;coenzyme biosynthetic process;7.24553448741107e-05!GO:0000096;sulfur amino acid metabolic process;7.24553448741107e-05!GO:0016628;oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor;7.38833737761916e-05!GO:0005839;proteasome core complex (sensu Eukaryota);7.49952284557448e-05!GO:0016853;isomerase activity;7.54797572616773e-05!GO:0015077;monovalent inorganic cation transmembrane transporter activity;8.66341592063964e-05!GO:0051287;NAD binding;9.47670217772802e-05!GO:0031965;nuclear membrane;9.90476094218664e-05!GO:0006695;cholesterol biosynthetic process;0.000101198735860272!GO:0006006;glucose metabolic process;0.000110289425094092!GO:0001568;blood vessel development;0.000116632962333879!GO:0065008;regulation of biological quality;0.000123605175651719!GO:0043412;biopolymer modification;0.000135439709653284!GO:0005624;membrane fraction;0.000142294134671084!GO:0043228;non-membrane-bound organelle;0.000143989553273713!GO:0043232;intracellular non-membrane-bound organelle;0.000143989553273713!GO:0045259;proton-transporting ATP synthase complex;0.000147692230809001!GO:0005791;rough endoplasmic reticulum;0.000149961991066614!GO:0006793;phosphorus metabolic process;0.000151611604095603!GO:0006796;phosphate metabolic process;0.000151611604095603!GO:0019842;vitamin binding;0.00015309844702486!GO:0003779;actin binding;0.000164348597772001!GO:0006164;purine nucleotide biosynthetic process;0.000174056668303044!GO:0016563;transcription activator activity;0.000184315178664911!GO:0044440;endosomal part;0.00019831626339869!GO:0010008;endosome membrane;0.00019831626339869!GO:0043283;biopolymer metabolic process;0.00019831626339869!GO:0016769;transferase activity, transferring nitrogenous groups;0.0001987959468566!GO:0015918;sterol transport;0.000228834873753137!GO:0030301;cholesterol transport;0.000228834873753137!GO:0008652;amino acid biosynthetic process;0.000237328676361885!GO:0030867;rough endoplasmic reticulum membrane;0.000237328676361885!GO:0006464;protein modification process;0.00024295370236915!GO:0006417;regulation of translation;0.000260449234892076!GO:0009260;ribonucleotide biosynthetic process;0.000281063667260278!GO:0003924;GTPase activity;0.000285929512405627!GO:0019318;hexose metabolic process;0.000285929512405627!GO:0009152;purine ribonucleotide biosynthetic process;0.00028597957203817!GO:0005996;monosaccharide metabolic process;0.000296645169282041!GO:0016481;negative regulation of transcription;0.000296645169282041!GO:0010035;response to inorganic substance;0.000308238281647379!GO:0016887;ATPase activity;0.000310919479204744!GO:0005579;membrane attack complex;0.000345506374031107!GO:0006612;protein targeting to membrane;0.000354168403347427!GO:0044431;Golgi apparatus part;0.000380177958746282!GO:0031326;regulation of cellular biosynthetic process;0.000390743333190232!GO:0050789;regulation of biological process;0.000401676062683862!GO:0016881;acid-amino acid ligase activity;0.000408744013876469!GO:0006508;proteolysis;0.000409296542429805!GO:0050878;regulation of body fluid levels;0.000443733477986259!GO:0004298;threonine endopeptidase activity;0.000443733477986259!GO:0040008;regulation of growth;0.000477904313495751!GO:0009889;regulation of biosynthetic process;0.000481809298080723!GO:0032553;ribonucleotide binding;0.000497439457442957!GO:0032555;purine ribonucleotide binding;0.000497439457442957!GO:0006959;humoral immune response;0.000509404590895162!GO:0031202;RNA splicing factor activity, transesterification mechanism;0.000531531209528773!GO:0005975;carbohydrate metabolic process;0.000550689891015365!GO:0007264;small GTPase mediated signal transduction;0.000550689891015365!GO:0005525;GTP binding;0.000554443326209939!GO:0022890;inorganic cation transmembrane transporter activity;0.00058382494760119!GO:0008654;phospholipid biosynthetic process;0.000592482238565006!GO:0045934;negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.000604118854280641!GO:0043687;post-translational protein modification;0.000624548224371761!GO:0045786;negative regulation of progression through cell cycle;0.000643307302238113!GO:0048471;perinuclear region of cytoplasm;0.00065665967259529!GO:0016765;transferase activity, transferring alkyl or aryl (other than methyl) groups;0.000666707907269108!GO:0000097;sulfur amino acid biosynthetic process;0.000710028882626089!GO:0046394;carboxylic acid biosynthetic process;0.00072085407701077!GO:0016053;organic acid biosynthetic process;0.00072085407701077!GO:0008250;oligosaccharyl transferase complex;0.000824225429858963!GO:0006979;response to oxidative stress;0.000841894469928944!GO:0005798;Golgi-associated vesicle;0.000845902280777532!GO:0030133;transport vesicle;0.000879662287784878!GO:0004579;dolichyl-diphosphooligosaccharide-protein glycotransferase activity;0.000881440828988825!GO:0009074;aromatic amino acid family catabolic process;0.000916797351880955!GO:0043566;structure-specific DNA binding;0.000943930783967033!GO:0004857;enzyme inhibitor activity;0.00097693106959515!GO:0032446;protein modification by small protein conjugation;0.00100364870004432!GO:0000245;spliceosome assembly;0.00103018552278487!GO:0015931;nucleobase, nucleoside, nucleotide and nucleic acid transport;0.00104325087356167!GO:0065007;biological regulation;0.00105840106307096!GO:0030139;endocytic vesicle;0.00107384322927903!GO:0005741;mitochondrial outer membrane;0.001081214376421!GO:0044453;nuclear membrane part;0.00109570862264962!GO:0031968;organelle outer membrane;0.00112713605170319!GO:0010033;response to organic substance;0.00119039117585198!GO:0019867;outer membrane;0.00132561377209727!GO:0016567;protein ubiquitination;0.00135688089220163!GO:0004576;oligosaccharyl transferase activity;0.00137826315057501!GO:0042623;ATPase activity, coupled;0.0015261737190225!GO:0030212;hyaluronan metabolic process;0.00163316299172076!GO:0016705;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;0.00165358673833974!GO:0001726;ruffle;0.00169965629189304!GO:0008206;bile acid metabolic process;0.0017607240328113!GO:0030100;regulation of endocytosis;0.00181634601603328!GO:0045261;proton-transporting ATP synthase complex, catalytic core F(1);0.00182909958965653!GO:0051920;peroxiredoxin activity;0.00183389511426356!GO:0004364;glutathione transferase activity;0.00183629342756263!GO:0016310;phosphorylation;0.00183629342756263!GO:0009719;response to endogenous stimulus;0.00184703692695569!GO:0001525;angiogenesis;0.00186453749645331!GO:0006643;membrane lipid metabolic process;0.00186453749645331!GO:0019395;fatty acid oxidation;0.00188306854223486!GO:0042625;ATPase activity, coupled to transmembrane movement of ions;0.0020004740769369!GO:0033116;ER-Golgi intermediate compartment membrane;0.00202571924843871!GO:0050794;regulation of cellular process;0.00205771267602672!GO:0006518;peptide metabolic process;0.00206929561381735!GO:0030554;adenyl nucleotide binding;0.0020998465946021!GO:0030532;small nuclear ribonucleoprotein complex;0.00212883295384521!GO:0033673;negative regulation of kinase activity;0.00212916063468055!GO:0006469;negative regulation of protein kinase activity;0.00212916063468055!GO:0048514;blood vessel morphogenesis;0.00212925399902387!GO:0051659;maintenance of mitochondrion localization;0.00213029858200033!GO:0051657;maintenance of organelle localization;0.00213029858200033!GO:0048468;cell development;0.00213105738050597!GO:0016197;endosome transport;0.00220912802542099!GO:0016408;C-acyltransferase activity;0.00230870888782751!GO:0006357;regulation of transcription from RNA polymerase II promoter;0.00234003506570717!GO:0016903;oxidoreductase activity, acting on the aldehyde or oxo group of donors;0.00238353554787801!GO:0045792;negative regulation of cell size;0.00240284892565716!GO:0033178;proton-transporting two-sector ATPase complex, catalytic domain;0.00240284892565716!GO:0006487;protein amino acid N-linked glycosylation;0.00242959541752166!GO:0006725;aromatic compound metabolic process;0.00250178941080905!GO:0043021;ribonucleoprotein binding;0.00260558705657306!GO:0032561;guanyl ribonucleotide binding;0.00263116193784993!GO:0019001;guanyl nucleotide binding;0.00263116193784993!GO:0005774;vacuolar membrane;0.00264629742184456!GO:0019843;rRNA binding;0.00274903492285597!GO:0008483;transaminase activity;0.00277871322760004!GO:0030308;negative regulation of cell growth;0.00279277786510987!GO:0051427;hormone receptor binding;0.00285382922418954!GO:0019838;growth factor binding;0.00294021500073357!GO:0005885;Arp2/3 protein complex;0.00298920330984298!GO:0050657;nucleic acid transport;0.003005378616175!GO:0051236;establishment of RNA localization;0.003005378616175!GO:0050658;RNA transport;0.003005378616175!GO:0006558;L-phenylalanine metabolic process;0.00317074685625151!GO:0006559;L-phenylalanine catabolic process;0.00317074685625151!GO:0009069;serine family amino acid metabolic process;0.00317074685625151!GO:0006635;fatty acid beta-oxidation;0.00327100137599813!GO:0055088;lipid homeostasis;0.00330459854402851!GO:0051270;regulation of cell motility;0.00332028469254655!GO:0016860;intramolecular oxidoreductase activity;0.00332293983204084!GO:0005159;insulin-like growth factor receptor binding;0.00344010339235183!GO:0005643;nuclear pore;0.00344438186998749!GO:0016679;oxidoreductase activity, acting on diphenols and related substances as donors;0.00344438186998749!GO:0016681;oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor;0.00344438186998749!GO:0008121;ubiquinol-cytochrome-c reductase activity;0.00344438186998749!GO:0031960;response to corticosteroid stimulus;0.0034698518334515!GO:0006953;acute-phase response;0.00348837703985367!GO:0005762;mitochondrial large ribosomal subunit;0.00359484804186473!GO:0000315;organellar large ribosomal subunit;0.00359484804186473!GO:0006403;RNA localization;0.00372895084108567!GO:0003690;double-stranded DNA binding;0.0037545979691502!GO:0016829;lyase activity;0.0037566326607574!GO:0045892;negative regulation of transcription, DNA-dependent;0.0037871694115743!GO:0010038;response to metal ion;0.0038054177818482!GO:0030027;lamellipodium;0.0038054177818482!GO:0000151;ubiquitin ligase complex;0.00385780480756596!GO:0044242;cellular lipid catabolic process;0.00393280326193482!GO:0016859;cis-trans isomerase activity;0.00429014125002474!GO:0055086;nucleobase, nucleoside and nucleotide metabolic process;0.00439216480798021!GO:0002449;lymphocyte mediated immunity;0.00439544084702583!GO:0009966;regulation of signal transduction;0.00445982166635498!GO:0006693;prostaglandin metabolic process;0.00451855571520019!GO:0006692;prostanoid metabolic process;0.00451855571520019!GO:0051348;negative regulation of transferase activity;0.00454463925783499!GO:0035257;nuclear hormone receptor binding;0.00467694326495799!GO:0000139;Golgi membrane;0.00468146133001633!GO:0003724;RNA helicase activity;0.00478020085393239!GO:0045454;cell redox homeostasis;0.0047993280647527!GO:0018196;peptidyl-asparagine modification;0.00500413733810898!GO:0018279;protein amino acid N-linked glycosylation via asparagine;0.00500413733810898!GO:0003857;3-hydroxyacyl-CoA dehydrogenase activity;0.00506517465545491!GO:0004300;enoyl-CoA hydratase activity;0.00537083648179923!GO:0007005;mitochondrion organization and biogenesis;0.00548628138830255!GO:0002684;positive regulation of immune system process;0.00565860030260707!GO:0003755;peptidyl-prolyl cis-trans isomerase activity;0.00585953187666451!GO:0002250;adaptive immune response;0.00592715652462666!GO:0002460;adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;0.00592715652462666!GO:0005577;fibrinogen complex;0.00620252262725298!GO:0006644;phospholipid metabolic process;0.00627598892131901!GO:0016740;transferase activity;0.0064551445951466!GO:0016591;DNA-directed RNA polymerase II, holoenzyme;0.00657947324539667!GO:0009725;response to hormone stimulus;0.00706249476085666!GO:0005753;mitochondrial proton-transporting ATP synthase complex;0.00706898909400804!GO:0065009;regulation of a molecular function;0.00709946251359662!GO:0030218;erythrocyte differentiation;0.00754336980818144!GO:0051540;metal cluster binding;0.00783432122870037!GO:0051536;iron-sulfur cluster binding;0.00783432122870037!GO:0006790;sulfur metabolic process;0.00788118634238816!GO:0005769;early endosome;0.00800420219678626!GO:0048500;signal recognition particle;0.00810007284754469!GO:0030118;clathrin coat;0.00813634271888163!GO:0051235;maintenance of localization;0.00820150404280587!GO:0005905;coated pit;0.00825374253080085!GO:0003697;single-stranded DNA binding;0.00851233795249572!GO:0050778;positive regulation of immune response;0.00919171010661004!GO:0006650;glycerophospholipid metabolic process;0.00924649869992426!GO:0051087;chaperone binding;0.00930177969100216!GO:0019210;kinase inhibitor activity;0.00930177969100216!GO:0016876;ligase activity, forming aminoacyl-tRNA and related compounds;0.00930177969100216!GO:0004812;aminoacyl-tRNA ligase activity;0.00930177969100216!GO:0016875;ligase activity, forming carbon-oxygen bonds;0.00930177969100216!GO:0009967;positive regulation of signal transduction;0.00946773417347671!GO:0051384;response to glucocorticoid stimulus;0.00961214923159277!GO:0015405;P-P-bond-hydrolysis-driven transmembrane transporter activity;0.00961214923159277!GO:0015399;primary active transmembrane transporter activity;0.00961214923159277!GO:0065002;intracellular protein transport across a membrane;0.0098725191592826!GO:0043623;cellular protein complex assembly;0.00987272282064881!GO:0006879;cellular iron ion homeostasis;0.010052026451469!GO:0055072;iron ion homeostasis;0.010052026451469!GO:0009081;branched chain family amino acid metabolic process;0.010052026451469!GO:0051179;localization;0.0102136688575429!GO:0042157;lipoprotein metabolic process;0.0102397169989504!GO:0008209;androgen metabolic process;0.0103557283290245!GO:0030530;heterogeneous nuclear ribonucleoprotein complex;0.010458633827516!GO:0030132;clathrin coat of coated pit;0.0105095814231935!GO:0002682;regulation of immune system process;0.010666557151135!GO:0045926;negative regulation of growth;0.0109558236281659!GO:0044437;vacuolar part;0.0110151913656994!GO:0000314;organellar small ribosomal subunit;0.0111229778271691!GO:0005763;mitochondrial small ribosomal subunit;0.0111229778271691!GO:0030134;ER to Golgi transport vesicle;0.0112574244002657!GO:0006767;water-soluble vitamin metabolic process;0.0114093371282745!GO:0002443;leukocyte mediated immunity;0.0117059949044654!GO:0051101;regulation of DNA binding;0.0117157055128143!GO:0051128;regulation of cellular component organization and biogenesis;0.0117157055128143!GO:0050660;FAD binding;0.0119181437342861!GO:0008047;enzyme activator activity;0.0119866548617527!GO:0006525;arginine metabolic process;0.0122174483988261!GO:0007040;lysosome organization and biogenesis;0.0122174483988261!GO:0016862;intramolecular oxidoreductase activity, interconverting keto- and enol-groups;0.0123118416343057!GO:0005524;ATP binding;0.0124687565304165!GO:0009991;response to extracellular stimulus;0.0128725192843435!GO:0030041;actin filament polymerization;0.0131646413908124!GO:0040011;locomotion;0.013303004070834!GO:0043038;amino acid activation;0.013303004070834!GO:0006418;tRNA aminoacylation for protein translation;0.013303004070834!GO:0043039;tRNA aminoacylation;0.013303004070834!GO:0005083;small GTPase regulator activity;0.0133219649402555!GO:0030127;COPII vesicle coat;0.0135458369524867!GO:0012507;ER to Golgi transport vesicle membrane;0.0135458369524867!GO:0051252;regulation of RNA metabolic process;0.0136239153375868!GO:0004860;protein kinase inhibitor activity;0.0136845954955533!GO:0051248;negative regulation of protein metabolic process;0.0138153687962963!GO:0040012;regulation of locomotion;0.0140603339450514!GO:0032559;adenyl ribonucleotide binding;0.0145034588730701!GO:0002252;immune effector process;0.0145355970790357!GO:0009117;nucleotide metabolic process;0.0145997945177297!GO:0015036;disulfide oxidoreductase activity;0.0146609758737128!GO:0005667;transcription factor complex;0.0146952281757446!GO:0006572;tyrosine catabolic process;0.014701009436804!GO:0008154;actin polymerization and/or depolymerization;0.01499827297493!GO:0006614;SRP-dependent cotranslational protein targeting to membrane;0.015099242739623!GO:0045047;protein targeting to ER;0.015099242739623!GO:0043492;ATPase activity, coupled to movement of substances;0.015325104140855!GO:0016676;oxidoreductase activity, acting on heme group of donors, oxygen as acceptor;0.0153716211640741!GO:0015002;heme-copper terminal oxidase activity;0.0153716211640741!GO:0016675;oxidoreductase activity, acting on heme group of donors;0.0153716211640741!GO:0004129;cytochrome-c oxidase activity;0.0153716211640741!GO:0043284;biopolymer biosynthetic process;0.0153716211640741!GO:0006706;steroid catabolic process;0.0155839766025483!GO:0031589;cell-substrate adhesion;0.0156819928552587!GO:0031667;response to nutrient levels;0.0157684333490396!GO:0005765;lysosomal membrane;0.0158339325145785!GO:0004029;aldehyde dehydrogenase (NAD) activity;0.015924115760296!GO:0016820;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;0.0162049269964072!GO:0016791;phosphoric monoester hydrolase activity;0.0162049269964072!GO:0055092;sterol homeostasis;0.0164787952016556!GO:0042632;cholesterol homeostasis;0.0164787952016556!GO:0045893;positive regulation of transcription, DNA-dependent;0.0165990621936419!GO:0004177;aminopeptidase activity;0.0167040456159107!GO:0007050;cell cycle arrest;0.0169268255931579!GO:0008186;RNA-dependent ATPase activity;0.0169268255931579!GO:0030170;pyridoxal phosphate binding;0.0169327883616943!GO:0006259;DNA metabolic process;0.0170099966504355!GO:0006633;fatty acid biosynthetic process;0.0170921206276471!GO:0005852;eukaryotic translation initiation factor 3 complex;0.0173938152767486!GO:0007265;Ras protein signal transduction;0.017515322718679!GO:0006139;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.0175529353144701!GO:0051028;mRNA transport;0.0175995762655424!GO:0046364;monosaccharide biosynthetic process;0.0185213811334391!GO:0046165;alcohol biosynthetic process;0.0185213811334391!GO:0042626;ATPase activity, coupled to transmembrane movement of substances;0.018570388753903!GO:0035258;steroid hormone receptor binding;0.0185952842048151!GO:0051674;localization of cell;0.0186628838204862!GO:0006928;cell motility;0.0186628838204862!GO:0043488;regulation of mRNA stability;0.0186973021123568!GO:0043487;regulation of RNA stability;0.0186973021123568!GO:0031072;heat shock protein binding;0.0188553882333598!GO:0000074;regulation of progression through cell cycle;0.0190779866405784!GO:0017166;vinculin binding;0.0192382406690733!GO:0006702;androgen biosynthetic process;0.0192387938950695!GO:0051726;regulation of cell cycle;0.0192387938950695!GO:0048659;smooth muscle cell proliferation;0.0192399917073786!GO:0006778;porphyrin metabolic process;0.0194022927521873!GO:0033013;tetrapyrrole metabolic process;0.0194022927521873!GO:0051591;response to cAMP;0.019631285222829!GO:0051168;nuclear export;0.019960615233976!GO:0005786;signal recognition particle, endoplasmic reticulum targeting;0.0204596339798453!GO:0050811;GABA receptor binding;0.020845450764561!GO:0016709;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen;0.0209421995337807!GO:0006402;mRNA catabolic process;0.0214691238975259!GO:0007162;negative regulation of cell adhesion;0.0215254193046965!GO:0008201;heparin binding;0.0216615832517541!GO:0001887;selenium metabolic process;0.021667246780369!GO:0042627;chylomicron;0.0216990083292611!GO:0031327;negative regulation of cellular biosynthetic process;0.0217222378176919!GO:0016712;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;0.0217617331424088!GO:0005520;insulin-like growth factor binding;0.0221639347970595!GO:0005665;DNA-directed RNA polymerase II, core complex;0.0222990133507016!GO:0030658;transport vesicle membrane;0.0226988689338131!GO:0015923;mannosidase activity;0.0228398795039155!GO:0008026;ATP-dependent helicase activity;0.022906084211644!GO:0003988;acetyl-CoA C-acyltransferase activity;0.0231994094662253!GO:0043681;protein import into mitochondrion;0.0232769873929283!GO:0042803;protein homodimerization activity;0.0239542350324993!GO:0048487;beta-tubulin binding;0.0239814234787019!GO:0042026;protein refolding;0.0241014683322376!GO:0007033;vacuole organization and biogenesis;0.0241781116599259!GO:0043065;positive regulation of apoptosis;0.0242392915796742!GO:0016780;phosphotransferase activity, for other substituted phosphate groups;0.0242392915796742!GO:0003746;translation elongation factor activity;0.024483024948591!GO:0009066;aspartate family amino acid metabolic process;0.0246135550047556!GO:0045637;regulation of myeloid cell differentiation;0.0246705998003861!GO:0019904;protein domain specific binding;0.0248848722495216!GO:0050776;regulation of immune response;0.0249186494067095!GO:0008312;7S RNA binding;0.0249393282867836!GO:0016836;hydro-lyase activity;0.025550088727795!GO:0030193;regulation of blood coagulation;0.026398106455112!GO:0050749;apolipoprotein E receptor binding;0.0264963492640664!GO:0004197;cysteine-type endopeptidase activity;0.0264963492640664!GO:0007160;cell-matrix adhesion;0.0265059200790661!GO:0003729;mRNA binding;0.0267075123802626!GO:0000041;transition metal ion transport;0.0267115992083533!GO:0046467;membrane lipid biosynthetic process;0.0268486791087885!GO:0030518;steroid hormone receptor signaling pathway;0.026918745027006!GO:0006090;pyruvate metabolic process;0.0270333878077421!GO:0005048;signal sequence binding;0.0270716058819878!GO:0030119;AP-type membrane coat adaptor complex;0.0271471445734578!GO:0050748;negative regulation of lipoprotein metabolic process;0.0274031696789752!GO:0008234;cysteine-type peptidase activity;0.0278568481323588!GO:0000122;negative regulation of transcription from RNA polymerase II promoter;0.0280940596816695!GO:0046904;calcium oxalate binding;0.0285753928063461!GO:0030568;plasmin inhibitor activity;0.0285753928063461!GO:0031902;late endosome membrane;0.0287902515765401!GO:0042168;heme metabolic process;0.0294018446037128!GO:0048646;anatomical structure formation;0.0294212535521512!GO:0006890;retrograde vesicle-mediated transport, Golgi to ER;0.0295344220296051!GO:0016877;ligase activity, forming carbon-sulfur bonds;0.0297075968078685!GO:0006607;NLS-bearing substrate import into nucleus;0.0297291981038396!GO:0019319;hexose biosynthetic process;0.0301487307118069!GO:0007242;intracellular signaling cascade;0.0306257259836893!GO:0015682;ferric iron transport;0.0307232265506591!GO:0015091;ferric iron transmembrane transporter activity;0.0307232265506591!GO:0031643;positive regulation of myelination;0.0307232265506591!GO:0006081;aldehyde metabolic process;0.030970272695179!GO:0033344;cholesterol efflux;0.0313845281247535!GO:0016281;eukaryotic translation initiation factor 4F complex;0.0316628023566262!GO:0003995;acyl-CoA dehydrogenase activity;0.0317353672132285!GO:0030131;clathrin adaptor complex;0.0317473707819535!GO:0006414;translational elongation;0.0319569168329586!GO:0051346;negative regulation of hydrolase activity;0.0320481480659295!GO:0031227;intrinsic to endoplasmic reticulum membrane;0.0324271180221146!GO:0051098;regulation of binding;0.0324635032672969!GO:0007010;cytoskeleton organization and biogenesis;0.0336479644612507!GO:0016620;oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor;0.0338870904215323!GO:0043068;positive regulation of programmed cell death;0.0349239500875443!GO:0051539;4 iron, 4 sulfur cluster binding;0.0349239500875443!GO:0005938;cell cortex;0.0353406052325334!GO:0006595;polyamine metabolic process;0.0359213283350478!GO:0003702;RNA polymerase II transcription factor activity;0.0363266883432793!GO:0046686;response to cadmium ion;0.0368899312838371!GO:0016746;transferase activity, transferring acyl groups;0.0370372767351477!GO:0030176;integral to endoplasmic reticulum membrane;0.0370372767351477!GO:0016229;steroid dehydrogenase activity;0.0372264268863341!GO:0003756;protein disulfide isomerase activity;0.0372264268863341!GO:0016864;intramolecular oxidoreductase activity, transposing S-S bonds;0.0372264268863341!GO:0004004;ATP-dependent RNA helicase activity;0.0373538890992796!GO:0001889;liver development;0.0375718680985454!GO:0030155;regulation of cell adhesion;0.0377171413194423!GO:0004386;helicase activity;0.0377588704506311!GO:0042254;ribosome biogenesis and assembly;0.0379847917564792!GO:0046395;carboxylic acid catabolic process;0.0382389703845013!GO:0016054;organic acid catabolic process;0.0382389703845013!GO:0030569;chymotrypsin inhibitor activity;0.0382389703845013!GO:0051271;negative regulation of cell motility;0.0385710421964322!GO:0006749;glutathione metabolic process;0.0385899290377601!GO:0043433;negative regulation of transcription factor activity;0.0392364433918146!GO:0030695;GTPase regulator activity;0.0392533632788218!GO:0006509;membrane protein ectodomain proteolysis;0.0392974209725094!GO:0033619;membrane protein proteolysis;0.0392974209725094!GO:0051537;2 iron, 2 sulfur cluster binding;0.0394483176792962!GO:0050818;regulation of coagulation;0.0396279502216662!GO:0000050;urea cycle;0.0397373600771518!GO:0043603;amide metabolic process;0.0397373600771518!GO:0019627;urea metabolic process;0.0397373600771518!GO:0008430;selenium binding;0.0398489317396233!GO:0009890;negative regulation of biosynthetic process;0.0399722424392336!GO:0051049;regulation of transport;0.0400419207346681!GO:0016747;transferase activity, transferring groups other than amino-acyl groups;0.0400419207346681!GO:0008139;nuclear localization sequence binding;0.0401092046654037!GO:0006892;post-Golgi vesicle-mediated transport;0.0404258360198008!GO:0000060;protein import into nucleus, translocation;0.0404258360198008!GO:0007049;cell cycle;0.0406208370173933!GO:0043086;negative regulation of catalytic activity;0.0411702618689316!GO:0004185;serine carboxypeptidase activity;0.0411898705182891!GO:0006007;glucose catabolic process;0.0422575901058419!GO:0006818;hydrogen transport;0.0424795401328847!GO:0006891;intra-Golgi vesicle-mediated transport;0.0426133233971517!GO:0004563;beta-N-acetylhexosaminidase activity;0.0428053179952504!GO:0017015;regulation of transforming growth factor beta receptor signaling pathway;0.0428053179952504!GO:0001725;stress fiber;0.0428192404090304!GO:0032432;actin filament bundle;0.0428192404090304!GO:0045941;positive regulation of transcription;0.0436002069855221!GO:0009607;response to biotic stimulus;0.0436506174312004!GO:0016721;oxidoreductase activity, acting on superoxide radicals as acceptor;0.0436506174312004!GO:0004784;superoxide dismutase activity;0.0436506174312004!GO:0009064;glutamine family amino acid metabolic process;0.0441804415447683!GO:0006094;gluconeogenesis;0.0443882411289805!GO:0015629;actin cytoskeleton;0.0443882411289805!GO:0035035;histone acetyltransferase binding;0.0445458242138249!GO:0042558;pteridine and derivative metabolic process;0.0458276738991501!GO:0008283;cell proliferation;0.045835457091076!GO:0016667;oxidoreductase activity, acting on sulfur group of donors;0.0458462274233892!GO:0002474;antigen processing and presentation of peptide antigen via MHC class I;0.0458462274233892!GO:0008147;structural constituent of bone;0.0458462274233892!GO:0007034;vacuolar transport;0.0458462274233892!GO:0006534;cysteine metabolic process;0.0460164651867364!GO:0030663;COPI coated vesicle membrane;0.0462240127059657!GO:0030126;COPI vesicle coat;0.0462240127059657!GO:0016568;chromatin modification;0.0478446925167803!GO:0030235;nitric-oxide synthase regulator activity;0.0480892539850115!GO:0005099;Ras GTPase activator activity;0.048264283067253!GO:0000062;acyl-CoA binding;0.0483957482061263!GO:0006658;phosphatidylserine metabolic process;0.0485599444973393!GO:0044438;microbody part;0.0485599444973393!GO:0044439;peroxisomal part;0.0485599444973393!GO:0005096;GTPase activator activity;0.0492743998656328!GO:0005838;proteasome regulatory particle (sensu Eukaryota);0.0495414244425057!GO:0006642;triacylglycerol mobilization;0.0496589872155483!GO:0045646;regulation of erythrocyte differentiation;0.0497520198885502!GO:0006563;L-serine metabolic process;0.0498809862106637
|sample_id=10003
|sample_id=10003
|sample_note=
|sample_note=
Line 78: Line 76:
|sample_tissue=whole body
|sample_tissue=whole body
|top_motifs=HLF:4.02605674701;NR1H4:3.8059256142;TBP:3.13739641578;ESRRA:2.75336086294;FOXA2:2.70057190096;NR5A1,2:2.61877086395;FOX{F1,F2,J1}:2.53317881297;NR3C1:2.4873052594;PAX1,9:2.28733939418;ESR1:2.27200032969;HNF1A:2.26432285587;NFIL3:2.21409638017;HNF4A_NR2F1,2:1.89346664289;MYOD1:1.8625831093;AR:1.82742864942;NFE2L1:1.69117361571;NFIX:1.61083366982;MEF2{A,B,C,D}:1.5969480987;JUN:1.56546234168;NKX3-2:1.47493600696;RXRA_VDR{dimer}:1.37730136552;RXR{A,B,G}_{NR1H2,PPAR}dimers:1.30395686134;STAT2,4,6:1.23648071167;GCM1,2:1.16645722591;CEBPA,B_DDIT3:1.16125743438;TBX4,5:1.09762423316;TFCP2:1.05608635665;TFAP4:1.0197083406;MAFB:0.990851446115;SNAI1..3:0.964591584687;LMO2:0.944762050457;ZNF148:0.93002391563;ALX1:0.890165602388;MYB:0.864831426373;FOXL1:0.838446750267;FOX{D1,D2}:0.82055022497;ZEB1:0.816499822605;GATA6:0.811125283874;HOX{A4,D4}:0.806282404593;SOX17:0.794574486852;RFX1:0.771868346754;T:0.764351275706;NFE2L2:0.722483583978;PPARG:0.668400356755;TFAP2{A,C}:0.655161863447;bHLH_family:0.641191564787;TLX2:0.636738797513;PBX1:0.589377145307;ATF6:0.585319047375;ARNT_ARNT2_BHLHB2_MAX_MYC_USF1:0.57566439449;NFE2:0.540323371706;RBPJ:0.537441003529;HAND1,2:0.493261100967;SRF:0.48863236904;RFX2..5_RFXANK_RFXAP:0.468916552099;EBF1:0.446307850906;HSF1,2:0.427578666751;TLX1..3_NFIC{dimer}:0.427159697462;FOSL2:0.382481650656;FOXO1,3,4:0.322757679171;LEF1_TCF7_TCF7L1,2:0.299561055161;TGIF1:0.296660354908;GTF2A1,2:0.286471392747;FOS_FOS{B,L1}_JUN{B,D}:0.275710992464;ONECUT1,2:0.24796599635;GFI1:0.231845981755;DMAP1_NCOR{1,2}_SMARC:0.219814574561;ZBTB6:0.192931674274;NHLH1,2:0.186861841543;NR6A1:0.168171886424;ZIC1..3:0.14263131405;TP53:0.139463196846;MYBL2:0.129849706912;SMAD1..7,9:0.128520323248;NKX2-3_NKX2-5:0.111913262285;MYFfamily:0.0866833850713;REST:0.0789749029167;MTF1:0.0266667172261;PDX1:0.00799187014254;TEAD1:-0.00736722065162;SOX5:-0.105499880506;CUX2:-0.116025100805;ATF2:-0.130839524556;PATZ1:-0.131191935919;PAX5:-0.151475073206;GLI1..3:-0.15302164139;STAT5{A,B}:-0.156283795773;PAX6:-0.180116732074;NFY{A,B,C}:-0.188985413491;RUNX1..3:-0.241956610345;TOPORS:-0.259418612076;POU1F1:-0.266530645199;IRF1,2:-0.301155915815;XCPE1{core}:-0.312558854678;NFATC1..3:-0.320858957203;RXR{A,B,G}:-0.329145219206;HIC1:-0.333307322737;HMX1:-0.343425305281;GTF2I:-0.354586607566;ATF5_CREB3:-0.364034759396;OCT4_SOX2{dimer}:-0.38603855084;POU2F1..3:-0.401014668964;ZNF423:-0.403944944078;SP1:-0.425923040919;GFI1B:-0.443138719544;ZNF238:-0.44321880747;ETS1,2:-0.447904303574;SPI1:-0.451647408932;HES1:-0.461939285392;IRF7:-0.469151194252;ALX4:-0.469887794087;KLF4:-0.484393852053;BACH2:-0.509891071281;HBP1_HMGB_SSRP1_UBTF:-0.515890459242;HOX{A5,B5}:-0.583686003703;YY1:-0.6035355563;SREBF1,2:-0.608748142261;MAZ:-0.617939789594;MED-1{core}:-0.624657349234;SOX{8,9,10}:-0.631171533736;NFKB1_REL_RELA:-0.637760247901;STAT1,3:-0.6574087723;POU6F1:-0.659673109714;HMGA1,2:-0.690038443995;EVI1:-0.692687935036;FOXM1:-0.721658014349;ADNP_IRX_SIX_ZHX:-0.755341259233;SPZ1:-0.76864603183;TFAP2B:-0.794351179;ATF4:-0.794984967542;RORA:-0.797908476965;NKX2-2,8:-0.803470115419;ARID5B:-0.809476291691;FOXN1:-0.907684035719;UFEwm:-0.952541884158;HOXA9_MEIS1:-0.966252982908;EN1,2:-0.966832723447;LHX3,4:-1.00304844011;E2F1..5:-1.0260727667;PAX8:-1.03709769101;BREu{core}:-1.04655920771;NRF1:-1.05740178182;FOXQ1:-1.06148893133;HIF1A:-1.07579959956;FOXP3:-1.07715059047;ELF1,2,4:-1.10012069094;PRRX1,2:-1.10767679972;ZFP161:-1.11379554429;SPIB:-1.12997400254;MZF1:-1.19254939433;AHR_ARNT_ARNT2:-1.24292555066;GATA4:-1.28183570258;GZF1:-1.28373630079;IKZF1:-1.29793935108;TAL1_TCF{3,4,12}:-1.29802035373;EGR1..3:-1.31864566529;RREB1:-1.32140043889;CREB1:-1.357154689;MTE{core}:-1.36391488095;POU3F1..4:-1.36806228364;PRDM1:-1.37452249749;POU5F1:-1.39724355254;CRX:-1.41214533151;IKZF2:-1.46416945517;ZNF143:-1.49300432952;PAX2:-1.49371710428;VSX1,2:-1.51555326335;NANOG{mouse}:-1.52866117786;FOXD3:-1.54271728356;TEF:-1.59731812064;CDC5L:-1.66023265463;NKX2-1,4:-1.69901034668;SOX2:-1.77392376821;EP300:-1.81987950773;FOX{I1,J2}:-1.90331199109;ELK1,4_GABP{A,B1}:-1.96348666771;DBP:-1.96700647987;TFDP1:-2.02008794255;NKX6-1,2:-2.07480541708;NANOG:-2.09000557994;PITX1..3:-2.20755624232;BPTF:-2.23879617299;NKX3-1:-2.41570857831;ZNF384:-2.51285613124;CDX1,2,4:-2.96685840274;PAX4:-2.98453096572;ZBTB16:-3.1306197203;FOXP1:-3.2066641176;AIRE:-3.53918376021
|top_motifs=HLF:4.02605674701;NR1H4:3.8059256142;TBP:3.13739641578;ESRRA:2.75336086294;FOXA2:2.70057190096;NR5A1,2:2.61877086395;FOX{F1,F2,J1}:2.53317881297;NR3C1:2.4873052594;PAX1,9:2.28733939418;ESR1:2.27200032969;HNF1A:2.26432285587;NFIL3:2.21409638017;HNF4A_NR2F1,2:1.89346664289;MYOD1:1.8625831093;AR:1.82742864942;NFE2L1:1.69117361571;NFIX:1.61083366982;MEF2{A,B,C,D}:1.5969480987;JUN:1.56546234168;NKX3-2:1.47493600696;RXRA_VDR{dimer}:1.37730136552;RXR{A,B,G}_{NR1H2,PPAR}dimers:1.30395686134;STAT2,4,6:1.23648071167;GCM1,2:1.16645722591;CEBPA,B_DDIT3:1.16125743438;TBX4,5:1.09762423316;TFCP2:1.05608635665;TFAP4:1.0197083406;MAFB:0.990851446115;SNAI1..3:0.964591584687;LMO2:0.944762050457;ZNF148:0.93002391563;ALX1:0.890165602388;MYB:0.864831426373;FOXL1:0.838446750267;FOX{D1,D2}:0.82055022497;ZEB1:0.816499822605;GATA6:0.811125283874;HOX{A4,D4}:0.806282404593;SOX17:0.794574486852;RFX1:0.771868346754;T:0.764351275706;NFE2L2:0.722483583978;PPARG:0.668400356755;TFAP2{A,C}:0.655161863447;bHLH_family:0.641191564787;TLX2:0.636738797513;PBX1:0.589377145307;ATF6:0.585319047375;ARNT_ARNT2_BHLHB2_MAX_MYC_USF1:0.57566439449;NFE2:0.540323371706;RBPJ:0.537441003529;HAND1,2:0.493261100967;SRF:0.48863236904;RFX2..5_RFXANK_RFXAP:0.468916552099;EBF1:0.446307850906;HSF1,2:0.427578666751;TLX1..3_NFIC{dimer}:0.427159697462;FOSL2:0.382481650656;FOXO1,3,4:0.322757679171;LEF1_TCF7_TCF7L1,2:0.299561055161;TGIF1:0.296660354908;GTF2A1,2:0.286471392747;FOS_FOS{B,L1}_JUN{B,D}:0.275710992464;ONECUT1,2:0.24796599635;GFI1:0.231845981755;DMAP1_NCOR{1,2}_SMARC:0.219814574561;ZBTB6:0.192931674274;NHLH1,2:0.186861841543;NR6A1:0.168171886424;ZIC1..3:0.14263131405;TP53:0.139463196846;MYBL2:0.129849706912;SMAD1..7,9:0.128520323248;NKX2-3_NKX2-5:0.111913262285;MYFfamily:0.0866833850713;REST:0.0789749029167;MTF1:0.0266667172261;PDX1:0.00799187014254;TEAD1:-0.00736722065162;SOX5:-0.105499880506;CUX2:-0.116025100805;ATF2:-0.130839524556;PATZ1:-0.131191935919;PAX5:-0.151475073206;GLI1..3:-0.15302164139;STAT5{A,B}:-0.156283795773;PAX6:-0.180116732074;NFY{A,B,C}:-0.188985413491;RUNX1..3:-0.241956610345;TOPORS:-0.259418612076;POU1F1:-0.266530645199;IRF1,2:-0.301155915815;XCPE1{core}:-0.312558854678;NFATC1..3:-0.320858957203;RXR{A,B,G}:-0.329145219206;HIC1:-0.333307322737;HMX1:-0.343425305281;GTF2I:-0.354586607566;ATF5_CREB3:-0.364034759396;OCT4_SOX2{dimer}:-0.38603855084;POU2F1..3:-0.401014668964;ZNF423:-0.403944944078;SP1:-0.425923040919;GFI1B:-0.443138719544;ZNF238:-0.44321880747;ETS1,2:-0.447904303574;SPI1:-0.451647408932;HES1:-0.461939285392;IRF7:-0.469151194252;ALX4:-0.469887794087;KLF4:-0.484393852053;BACH2:-0.509891071281;HBP1_HMGB_SSRP1_UBTF:-0.515890459242;HOX{A5,B5}:-0.583686003703;YY1:-0.6035355563;SREBF1,2:-0.608748142261;MAZ:-0.617939789594;MED-1{core}:-0.624657349234;SOX{8,9,10}:-0.631171533736;NFKB1_REL_RELA:-0.637760247901;STAT1,3:-0.6574087723;POU6F1:-0.659673109714;HMGA1,2:-0.690038443995;EVI1:-0.692687935036;FOXM1:-0.721658014349;ADNP_IRX_SIX_ZHX:-0.755341259233;SPZ1:-0.76864603183;TFAP2B:-0.794351179;ATF4:-0.794984967542;RORA:-0.797908476965;NKX2-2,8:-0.803470115419;ARID5B:-0.809476291691;FOXN1:-0.907684035719;UFEwm:-0.952541884158;HOXA9_MEIS1:-0.966252982908;EN1,2:-0.966832723447;LHX3,4:-1.00304844011;E2F1..5:-1.0260727667;PAX8:-1.03709769101;BREu{core}:-1.04655920771;NRF1:-1.05740178182;FOXQ1:-1.06148893133;HIF1A:-1.07579959956;FOXP3:-1.07715059047;ELF1,2,4:-1.10012069094;PRRX1,2:-1.10767679972;ZFP161:-1.11379554429;SPIB:-1.12997400254;MZF1:-1.19254939433;AHR_ARNT_ARNT2:-1.24292555066;GATA4:-1.28183570258;GZF1:-1.28373630079;IKZF1:-1.29793935108;TAL1_TCF{3,4,12}:-1.29802035373;EGR1..3:-1.31864566529;RREB1:-1.32140043889;CREB1:-1.357154689;MTE{core}:-1.36391488095;POU3F1..4:-1.36806228364;PRDM1:-1.37452249749;POU5F1:-1.39724355254;CRX:-1.41214533151;IKZF2:-1.46416945517;ZNF143:-1.49300432952;PAX2:-1.49371710428;VSX1,2:-1.51555326335;NANOG{mouse}:-1.52866117786;FOXD3:-1.54271728356;TEF:-1.59731812064;CDC5L:-1.66023265463;NKX2-1,4:-1.69901034668;SOX2:-1.77392376821;EP300:-1.81987950773;FOX{I1,J2}:-1.90331199109;ELK1,4_GABP{A,B1}:-1.96348666771;DBP:-1.96700647987;TFDP1:-2.02008794255;NKX6-1,2:-2.07480541708;NANOG:-2.09000557994;PITX1..3:-2.20755624232;BPTF:-2.23879617299;NKX3-1:-2.41570857831;ZNF384:-2.51285613124;CDX1,2,4:-2.96685840274;PAX4:-2.98453096572;ZBTB16:-3.1306197203;FOXP1:-3.2066641176;AIRE:-3.53918376021
|xref=
}}
}}

Revision as of 15:44, 27 June 2012


Name:SABiosciences XpressRef Mouse Universal Total RNA, pool1
Species:Mouse (Mus musculus)
Library ID:{{{library_id}}}
Sample type:{{{sample_category}}}
Genomic View: UCSC
CAGEd-oPOSSUM:link
Additional information
Sample information
strainNA
tissuewhole body
dev stageUNDEFINED
sexmixed
ageNA
cell typeCELL MIXTURE - tissue sample
cell lineNA
companySABiosciences
collaborationFANTOM5 OSC CORE (contact: Al Forrest)
External link for information[{{{sample_info_link}}} {{{sample_info_link}}}]
RNA information
lot numberA705103
catalog numberCat:GA-005
sample typetotal RNA
extraction protocol (Details)OP-RNA-extraction-totalRNA-TRIzol-isopropanol-v1.0
Download raw sequence, BAM & CTSS
Mm9
BAMCTSS
[{{{mm9bam}}} download][{{{mm9ctss}}} donwload]
Mm10
BAMCTSS
[{{{mm10bam}}} download][{{{mm10ctss}}} donwload]


Relative expression to median (log10)


Transcription factors with enriched expression in this sampleRanked list of transcription factor promoter expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.



Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data

CNhs10611

00.153
10.0571
100.0571
1000
10000.744
10010.11
1002-0.0334
10030.131
10040
10050.131
10060.596
1007-0.145
10081.177
10090.0974
101-0.0481
10100
10110.206
10120
10130.22
1014-0.0874
1015-0.193
1016-0.272
10170
10180.194
10190.297
1020
10200
10210
10220.741
10230
10240.144
10250.236
10260.194
10270
10280
1029-0.0685
1030.123
10300.108
1031-0.3
10320.174
1033-0.0737
10340.269
10350
1036-0.367
10370.108
1038-0.11
10390.502
1040
1040-0.158
10410.451



Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data no result for this sample


TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample


JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data

library id: CNhs10611

Jaspar motifP-value
MA0002.20.0556
MA0003.10.00892
MA0004.10.852
MA0006.10.279
MA0007.10.523
MA0009.10.162
MA0014.10.866
MA0017.12.24196e-10
MA0018.20.978
MA0019.10.903
MA0024.10.0125
MA0025.10.00948
MA0027.10.532
MA0028.10.0337
MA0029.10.446
MA0030.10.0262
MA0031.10.0268
MA0035.25.46371e-4
MA0038.10.901
MA0039.20.121
MA0040.10.0885
MA0041.10.264
MA0042.10.565
MA0043.10.378
MA0046.11.99647e-57
MA0047.26.87632e-4
MA0048.10.332
MA0050.10.344
MA0051.10.911
MA0052.14.35728e-7
MA0055.10.382
MA0057.10.255
MA0058.10.728
MA0059.10.795
MA0060.10.533
MA0061.10.806
MA0062.21.50984e-4
MA0065.22.17268e-10
MA0066.10.0906
MA0067.10.353
MA0068.10.683
MA0069.10.461
MA0070.10.966
MA0071.10.0398
MA0072.10.268
MA0073.10.848
MA0074.10.564
MA0076.10.00812
MA0077.10.832
MA0078.10.0537
MA0079.20.572
MA0080.20.165
MA0081.10.103
MA0083.10.217
MA0084.10.735
MA0087.10.922
MA0088.10.398
MA0090.10.112
MA0091.10.83
MA0092.10.338
MA0093.10.742
MA0099.20.509
MA0100.10.0415
MA0101.10.296
MA0102.20.955
MA0103.10.0203
MA0104.20.96
MA0105.10.157
MA0106.10.863
MA0107.10.228
MA0108.28.75735e-18
MA0111.10.413
MA0112.23.11231e-6
MA0113.10.393
MA0114.13.83557e-10
MA0115.16.07712e-7
MA0116.10.0351
MA0117.10.883
MA0119.10.0557
MA0122.10.636
MA0124.10.488
MA0125.10.433
MA0131.10.429
MA0135.10.624
MA0136.10.0191
MA0137.20.334
MA0138.21.7811e-4
MA0139.10.153
MA0140.10.0411
MA0141.12.92985e-4
MA0142.10.525
MA0143.10.0883
MA0144.10.638
MA0145.10.0186
MA0146.10.121
MA0147.10.871
MA0148.10.00108
MA0149.10.182
MA0150.10.0598
MA0152.10.138
MA0153.11.08698e-33
MA0154.10.0101
MA0155.10.206
MA0156.10.00361
MA0157.10.13
MA0159.10.00464
MA0160.11.75553e-5
MA0162.10.117
MA0163.10.001
MA0164.10.746
MA0258.11.009e-4
MA0259.10.304



FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data

library id: CNhs10611

Novel motifP-value
10.177
100.534
1000.724
1010.138
1020.797
1030.27
1040.368
1050.475
1060.0836
1070.147
1080.989
1090.0937
110.128
1100.228
1110.255
1120.0753
1130.598
1140.08
1150.628
1160.0657
1170.76
1180.708
1190.0623
120.599
1200.611
1210.0711
1220.447
1230.743
1240.78
1250.741
1260.437
1270.865
1280.167
1290.681
130.14
1300.639
1310.217
1320.588
1330.556
1340.916
1350.507
1360.211
1370.784
1380.989
1390.0577
140.314
1400.966
1410.43
1420.991
1430.926
1440.847
1450.276
1460.16
1470.874
1480.96
1490.268
150.318
1500.448
1510.303
1520.12
1530.596
1540.647
1550.873
1561.16178e-4
1570.607
1580.351
1590.476
1600.405
1610.717
1620.441
1630.842
1640.606
1650.199
1660.477
1670.303
1680.239
1690.00211
170.129
180.98
190.0768
20.34
200.547
210.66
220.147
230.153
240.0518
250.427
260.308
270.53
280.389
290.521
30.213
300.32
310.27
320.0213
330.64
340.302
350.527
360.436
370.133
380.41
390.388
40.601
400.0997
410.0295
420.512
430.206
440.0191
450.248
460.234
470.148
480.186
490.27
50.481
500.624
510.553
520.2
530.662
540.401
550.951
560.495
570.975
580.237
590.0169
60.663
600.15
610.853
620.115
630.105
640.437
650.22
660.604
670.589
680.478
690.514
70.271
700.0449
710.205
720.273
730.178
740.409
750.251
760.369
770.0615
780.558
790.366
80.018
800.265
810.435
820.045
830.232
840.104
850.0185
860.31
870.0196
880.36
890.0467
90.541
900.401
910.249
920.283
930.689
940.855
950.211
960.404
970.121
980.421
990.101



de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br> library id: CNhs10611


FANTOM5 (FF) ontology


Direct parent terms


Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data

UBERON: Anatomy
0000479 (tissue)
0000061 (anatomical structure)
0000465 (material anatomical entity)
0001062 (anatomical entity)

FF: FANTOM5
NA

Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA